Insights

Clinical Trial Services

Safely and Reliably Supplying your Comparator Needs during COVID19

Maintaining Safe and Reliable Supply of Comparators during COVID19 As an agile, well-distributed and robust global supplier of Comparators for the biopharmaceutical industry, Inceptua is uniquely positioned to safely and…
Medicines Access

Maintaining access to your medicines during COVID19

As an agile, global, and robust provider of medicines access programs for the biopharmaceutical industry, Inceptua is uniquely positioned to safely and reliably supply your products throughout the global crisis.…
Clinical Trial Services

How we are supporting with uninterrupted supply of medicines for clinical trials

In clinical trials, a Comparator drug, either an investigational or marketed product, is often required to determine the efficacy relative to a drug that is already on the market. Safe,…
Featured
Industry Trends in Pre-approval Access to Medicines
Medicines Access
The 21st Century Cures Act: Turn your obligations into an advantage
Update
Pre-Approval Access Policy
Clinical Trial Services
Navigating the Clinical Trial Supply Route in China
Update
Small Data for a Big Benefit
Clinical Trial Services
Inceptua Q&A: Comparator Sourcing for Clinical Trials
Medicines Access
Expediting Access to Rare Disease Therapies in Europe
Medicines Access
Providing Access to Unlicensed Medicines
Clinical Trial Services
How to navigate the challenges of a changing Chinese market
Featured
Commercialize and partner successfully in Europe and the Middle East
Clinical Trial Services
Race the hurdles of global clinical trials
Medicines Access
What life science companies need to know about pre-approval access

News and Press Releases

Featured

Global License Agreement a Building Block in Strategic Growth Plans

LUXEMBOURG – 23 March, 2020 – Inceptua – pharmaceutical company and service partner - and biopharmaceutical company Oxurion have announced a global license agreement for the commercialization of JETREA®, a…
Featured

Oxurion and Inceptua Group enter global license agreement for the commercialization of JETREA®

Press release: Oxurion and Inceptua Group enter global license agreement for the commercialization of JETREA® Oxurion announces the signing of a JETREA® global license agreement with Inceptua Group. JETREA® is…
Featured

Inceptua and Portola enter exclusive distribution agreement for Ondexxya®

LUXEMBOURG / SAN FRANCISCO – 7th February  2020 –  Inceptua, a global pharmaceutical company and service partner and Portola - US developer and manufacturer of therapeutic agents focusing on thrombosis…
Featured
Inceptua appoints new Head of Asia-Pacific, Clinical Trial Services
Press release
Inceptua and Onconova Therapeutics Announce Pre-approval Access Collaboration for Rigosertib in Selected Countries Outside the US
Press release
Inceptua appoints new President North America
Press release
Inceptua and Bendalis enter into an exclusive oncology medicine supply agreement for clinical trials
Press release
Inceptua appoints new CEO
News
HAEi Global Access Program Provides Life-saving Medication
Press release
Head of Global Patient Access joins Inceptua
Press release
New Chief Medical Officer joins Inceptua
Press release
Strong industry profiles join Inceptua
Press release
Creation of Inceptua Clinical Trial Services marks new era for the company
News
Pharming Group and HAEi International announce partnership with Inceptua for HAEi Global Access Program
Press release
Industry experts set to transform evolving pre-approval & unlicensed medicines sector with launch of Inceptua Medicines Access